Delaware (State or other jurisdiction of incorporation or organization) |
0-22705 (Commission File Number) |
33-0525145 (IRS Employer Identification No.) |
12790 El Camino Real (Address of principal executive offices) |
92130 (Zip Code) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c)) |
ITEM 8.01 OTHER EVENTS. | ||||||||
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. | ||||||||
SIGNATURES | ||||||||
EXHIBIT 99.1 |
Exhibit | ||
Number | Description of Exhibit | |
99.1
|
Press Release dated June 12, 2007 |
Dated: June 13, 2007 | NEUROCRINE BIOSCIENCES, INC. |
|||
/s/ TIMOTHY P. COUGHLIN | ||||
Timothy P. Coughlin | ||||
Vice President and Chief Financial Officer | ||||